The present disclosure relates generally to pharmaceuticals. More specifically, thedisclosure is directed to a pharmaceutical composition comprising apharmaceutically active component and an excipient, lyophilized pumpkin seedmucilage obtained from bio-waste pumpkin seeds. The mucilage is a suitableexcipient for functioning as a binder, a film former, a mucoadhesive agent, a10 release modifier, or combinations thereof. The disclosure also provides a processof preparation of the lyophilized pumpkin seed mucilage.
Rajni Bala, Reecha Madaan, Bharti Kaundle, Ravi Goyal